Specifically designed by the Society for Immunotherapy of Cancer (SITC), the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CNE- and CPE-certified programs, presented by leading, local authorities in tumor immunology and cancer immunotherapy.

These six-hour programs will:

  • Facilitate your understanding of the clinical applications of immunotherapy for disease states with FDA-approved treatments
  • Provide strategies for overcoming operational and reimbursement barriers to implementing immunotherapy in a community setting
  • Offer support in the identification and management of immune-related adverse events
Attendees will also have an opportunity to connect with regional experts in the immunotherapy field during the in-person event, in two post-program webinars and through a dedicated online SITC CONNECT community forum.

Upcoming Regional ACI Programs

Click any of the following links to learn more about these upcoming ACI regional education programs:




Registration Link

ACI-Charleston, SC

Saturday, Feb. 24, 2018

Charleston Marriott

Advance Registration Closed
(Onsite Registration is Available)

ACI-Dallas, TX

Saturday, March 3, 2018

DoubleTree by Hilton Hotel Dallas - Campbell Centre

Register Today

ACI-Live Webcast

Saturday, March 3, 2018


Register Today

ACI-Miami, FL

Saturday, March 10, 2018

Miami Marriott Biscayne Bay

Register Today

ACI-Buffalo, NY

Saturday, March 24, 2018

Embassy Suites by Hilton Buffalo

Register Today

Accessibility Image

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc.). Please contact SITC prior to the event at (414) 271-2456.

Introduction to Immunology - Pre-Program Class

IntrotoImmunology.pngIntroduction to Immunology is a free online pre-program class for the ACI regional education series. Participation ACI program attendees is strongly recommended, however the class is available to anyone free of charge.

This interactive class provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program.

Click here to access this free class.

The 2017-2018 Advances in Cancer Immunotherapy™ series is brought to you in collaboration with the American Academy of Emergency Medicine and Association of Community Cancer Centers.



Postgraduate Institute for MedicineSITC Logo  

Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer 

The 2017 Advances in Cancer Immunotherapy™ series is supported in part by independent medical educational grants from
  Aduro Biotech, Inc., Amgen, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Incyte Corporation, Merck & Co., Inc. and Prometheus Laboratories Inc.